Journal article · 2023 · Open access

Omicron (B.1.1.529) BA.1 or BA.2-related effects on immune responses in previously naïve versus imprinted individuals: immune imprinting as an advantage in the humoral immune response against novel variants

Sissy Therese Sonnleitner, Samira Walder, Ludwig Knabl, Roswitha Poernbacher, Thomas Tschurtschenthaler, Eva Hinterbichler, Stefanie Sonnleitner, Viktoria Muehlmann, Wilfried Posch, Gernot Walder

Frontiers in Immunology, 14, 1165769 · Published 15 May 2023 · DOI 10.3389/fimmu.2023.1165769

Open full textCite this paper

In brief

“Omicron (B.1.1.529) BA.1 or BA.2-related effects on immune responses in previously naïve versus imprinted individuals: immune imprinting as an advantage in the humoral immune response against novel variants” is a 2023 journal article by Sissy Therese Sonnleitner and 9 co-authors, published in Frontiers in Immunology. OpenAlex counts 2 citations as of 18 November 2026. It is open access under a CC BY licence: the full text is free to read at Frontiers in Immunology.

Citations
2
Most cited in
2023 (1)
Field-weighted impact
0.38
References
35
Authors
10

Abstract

Background: Immune imprinting is a phenomenon in which a person's immune system develops a specific immunological memory of the pathogen or vaccine due to a previous exposure. This memory basically leads to a faster and stronger immune response in a subsequent contact to the same pathogen or vaccine. However, what happens if the pathogen has changed considerably in the meantime due to mutations in the main target region of antibodies, as in the evolution of SARS-CoV-2 from the ancestral strain to B.1.1.529 (Omicron)? In this case, does immune imprinting also confer an advantage in repeated contact and does it lead to a stronger immune response? Methods: To clarify these questions, we investigated the effects of immune imprinting in the context of SARS-CoV-2 by comparing a group of previously infection-naïve versus imprinted study participants and determined differences in humoral and cellular immune responses during and after infection with strain SARS-CoV-2 B.1.1.529 BA.1 and BA.2, respectively. We used a commercial CLIA, immunoblots, IFN-γ ELISpots and a plaque-reduction neutralization test to generate a clear and comparable picture of the humoral and cellular immune response in the two study groups. Results: Imprinted participants developed significantly higher antibody titers and showed significantly stronger neutralization capacity against the ancestral strain, BA.1 and BA.5. The immune response of naïve study participants was narrower and related mainly to the receptor-binding domain, which resulted in a lower neutralization capacity against other strains including BA.5. Naïve study participants showed a significantly higher cellular immune response than the imprinted study group, indicating a higher antigenic challenge. The cellular immune response was directed against general structures of SARS-CoV-2 and not specifically against the receptor-binding domain. Conclusion: Viral variant infection elicits variant-specific antibodies and prior mRNA vaccination or infection with a previous SARS-CoV-2 variant imprints serological responses toward the ancestral strain rather than variant antigens. On the other hand, our study shows that the initially higher specific antibody titers due to former imprinting via vaccination or prior infection significantly increased the humoral immune response, and therefore outperformed the humoral immune response of naïve study participants.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Sonnleitner, S. T., Walder, S., Knabl, L., Poernbacher, R., Tschurtschenthaler, T., Hinterbichler, E., Sonnleitner, S., Muehlmann, V., Posch, W., & Walder, G. (2023). Omicron (B.1.1.529) BA.1 or BA.2-related effects on immune responses in previously naïve versus imprinted individuals: immune imprinting as an advantage in the humoral immune response against novel variants. Frontiers in Immunology, 14, 1165769. https://doi.org/10.3389/fimmu.2023.1165769

MLA 9

Sonnleitner, Sissy Therese, et al. “Omicron (B.1.1.529) BA.1 or BA.2-related effects on immune responses in previously naïve versus imprinted individuals: immune imprinting as an advantage in the humoral immune response against novel variants.” Frontiers in Immunology, vol. 14, 2023, p. 1165769. https://doi.org/10.3389/fimmu.2023.1165769.

Chicago

Sonnleitner, Sissy Therese, Samira Walder, Ludwig Knabl, Roswitha Poernbacher, Thomas Tschurtschenthaler, Eva Hinterbichler, Stefanie Sonnleitner, Viktoria Muehlmann, Wilfried Posch, and Gernot Walder. 2023. “Omicron (B.1.1.529) BA.1 or BA.2-related effects on immune responses in previously naïve versus imprinted individuals: immune imprinting as an advantage in the humoral immune response against novel variants.” Frontiers in Immunology 14: 1165769. https://doi.org/10.3389/fimmu.2023.1165769.

Harvard

Sonnleitner, S. T. et al. (2023) ‘Omicron (B.1.1.529) BA.1 or BA.2-related effects on immune responses in previously naïve versus imprinted individuals: immune imprinting as an advantage in the humoral immune response against novel variants’, Frontiers in Immunology, 14, p. 1165769. doi:10.3389/fimmu.2023.1165769.

IEEE

S. T. Sonnleitner et al., “Omicron (B.1.1.529) BA.1 or BA.2-related effects on immune responses in previously naïve versus imprinted individuals: immune imprinting as an advantage in the humoral immune response against novel variants,” Frontiers in Immunology, vol. 14, p. 1165769, 2023, doi: 10.3389/fimmu.2023.1165769.

BibTeX

@article{sonnleitner2023omicron,
  title     = {{Omicron (B.1.1.529) BA.1 or BA.2-related effects on immune responses in previously naïve versus imprinted individuals: immune imprinting as an advantage in the humoral immune response against novel variants}},
  author    = {Sonnleitner, Sissy Therese and Walder, Samira and Knabl, Ludwig and Poernbacher, Roswitha and Tschurtschenthaler, Thomas and Hinterbichler, Eva and Sonnleitner, Stefanie and Muehlmann, Viktoria and Posch, Wilfried and Walder, Gernot},
  journal   = {Frontiers in Immunology},
  year      = {2023},
  volume    = {14},
  pages     = {1165769},
  doi       = {10.3389/fimmu.2023.1165769},
  url       = {https://doi.org/10.3389/fimmu.2023.1165769}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research

  • immune imprinting
  • Omicron variant
  • BA.1
  • BA.2
  • BA.5
  • humoral immune response
  • cell-mediated immunity
  • neutralizing antibodies

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Sonnleitner, S. T., Walder, S., Knabl, L., Poernbacher, R., Tschurtschenthaler, T., Hinterbichler, E., Sonnleitner, S., Muehlmann, V., Posch, W., & Walder, G. (2023). Omicron (B.1.1.529) BA.1 or BA.2-related effects on immune responses in previously naïve versus imprinted individuals: immune imprinting as an advantage in the humoral immune response against novel variants. Frontiers in Immunology, 14, 1165769. https://doi.org/10.3389/fimmu.2023.1165769

How many times has this paper been cited?

2 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Frontiers in Immunology: sign in and open the full text from this page.

Who wrote this paper?

Sissy Therese Sonnleitner, Samira Walder, Ludwig Knabl, Roswitha Poernbacher, Thomas Tschurtschenthaler, Eva Hinterbichler, Stefanie Sonnleitner, Viktoria Muehlmann, Wilfried Posch, Gernot Walder.

What is the DOI of this paper?

10.3389/fimmu.2023.1165769, permanently at https://doi.org/10.3389/fimmu.2023.1165769. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.